Don’t be fooled by drug price hike pauses
Let's keep reality in focus: Drug companies don’t get credit for keeping prices high.
Not enough: Pfizer roll backs on drug price hikes are not a significant drug pricing reform
One-off tweets do not fix the systemic problems we have with drug prices. We need long-term structural action to provide enduring relief.
Patients For Affordable Drugs Delivers Petition Demanding Drug Giant Vertex Lower Its Prices
Vertex Brags About Sitting On More Than $2 Billion Cash But Refuses To Reduce Prices As Patients Suffer.
Patients For Affordable Drugs Sends U.S. Patients to United Nations
Patient Advocates to raise the issue of drug prices during discussions about non-communicable diseases.
Drug Corporations Ring in July with New Price Hikes
July brought warm weather and new price hikes for Americans already struggling under unfair list prices.
ICYMI: Medicare spent $2 billion for one drug as the manufacturer paid doctors millions
Medicare spent nearly $2 billion on H.P. Acthar Gel from 2011-2016, according to the agency's data — even though some doctors say an equally effective treatment would have cost a tiny fraction of that amount
My name is April. My breast cancer drug costs $13,000 a month. This is how I took a stand
My name is April. I live and work in Pensacola, Florida with my wonderful husband and our 11-year-old son. I also have incurable breast cancer.
How co-pay coupons and patient assistance are actually robbing us blind
Receiving assistance from a drug corporation to afford an expensive prescription feels a lot like pharma benevolence. Here's why these programs are robbing us blind:
